MRDAF: To Collaborate w/ Thorne Research on Cardio Study [delayed]

Ridgeland, MS, OCT 28, 2004 (EventX/Knobias.com via COMTEX) --

Meridian Co., Ltd. (MRDAF) announces that its subsidiary, Belgium Medical Inc. has commenced discussions regarding a collaborative study with Thorne Research Inc. The study will use the Digital Pulse Analyzer ("DPA") to test the effectiveness of Thorne's new product - Perfusia-SR. Perfusia-SR is a supplement that represents a revolutionary advancement in nutritional support for the heart and blood vessels. Perfusia-SR is a proprietary sustained-release L-arginine, which provides the body a constant source of nitric oxide, a substance vital in many metabolic processes in the body, especially the lining of the arteries.